Journal Guide

Leukemia & Lymphoma is an international journal that publishes full-length papers and reviews on clinical and therapeutic practice, epidemiological studies and outcomes analysis, laboratory diagnosis, pathology, cytology, ultrastructure, cytogenetics and cellular and molecular immunology of hematologic malignancies; the journal aims at a strong clinical-pathologic correlation. Letters and correspondence to the editors are also accepted on all topics, which are novel and provide new and interesting data for clinicians and postgraduate teaching. In addition, an update is provided on the basic issues and advances in molecular genetics as applied to this field. The journal will provide an important reference source for physicians and scientists who deal essentially with the clinical and laboratory diagnosis, clinical care and therapy of patients with these disorders.

Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Original research articles, early reports, review articles, commentaries and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review.

Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.

Manuscripts should be submitted online at http://ees.elsevier.com/lungcancer and the instructions on this site should be closely followed.

Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art Reviews on clinical and experimental therapies in oncology and hematology. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.

Melanoma Research fosters the development of translational research. It promotes the informational exchange between those engaged in the field. The Journal encourages an informed and balanced view of experimental and clinical research, and stimulates the communication and exchange of knowledge between investigators with differing areas of expertise. The Journal presents a coherent and up-to-date account of all aspects of investigations pertinent to melanoma. Consequently, the scope of the Journal is broad, embracing the entire range of studies from fundamental and applied research in such subject areas as genetics, molecular biology, biochemistry, cell biology, photobiology, pathology and immunology, and advances in clinical oncology influencing the prevention, diagnosis and treatment of melanoma. Website: www.melanomaresearch.com.

Molecular Cancer publishes high-quality original research and reviews that present or highlight significant advances in all areas of cancer-related biomedical science.

Molecular Cancer Research publishes original, novel, and well-designed studies on the molecular and cellular aspects of cancer biology. Papers should represent significant new information gathered from basic research that has implications for cancer therapeutics in one of the following areas: Angiogenesis, Metastasis, and the Cellular Microenvironment; Cancer Genes and Genomics; Cell Cycle, Cell Death, and Senescence; DNA Damage and Cellular Stress Responses; Model Organisms; and Signaling and Regulation. All submissions are peer reviewed and only those that meet high standards of scientific merit will be accepted for publication.

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.

Molecular Carcinogenesis presents information describing investigations of molecular aspects of the mechanisms involved in chemical, physical, and viral (biological) carcinogenesis. Areas of interest include, but are not limited to, the structure, expression, or function of genes or gene products associated with normal growth and differentiation and alterations in neoplasia; characterization of genes or gene products expressed in preneoplastic or neoplastic cells; molecular studies that define a specific function of a tumor-associated protein or its effects on cellular function; virtually all research on molecular aspects of oncogenes, tumor suppressor genes, and their gene products; carcinogenesis studies in transgenic mice; and research on human tumor viruses.

Molecular Imaging and Biology presents original research contributions on the utilization of molecular imaging in problems of relevance in biology and medicine. The primary objective of the journal is to provide a forum for the discovery of molecular mechanisms of health and disease through the use of imaging techniques. Among the topics covered are molecular imaging investigations of macromolecular targets involved in significant biological processes; design and evaluation of molecular probes used to investigate macromolecular targets and their functions; and study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics.The overall goal is to translate basic science discoveries into molecular imaging of disease in patients, both to investigate the biological nature of disease in actual patients and to establish new molecular imaging diagnostic procedures.Molecular Imaging and Biology is the official journal of the World Molecular Imaging Society and the Europea

* Biological Abstracts® (Thomson ISI) * BIOSIS Previews® (Thomson ISI) * Chemical Abstracts Service (CAS) * EMBASE (Elsevier) * Google Scholar * Index Copernicus (IC) * Index Medicus/MEDLINE/PubMed (NLM) * Journal Citation Reports (JCR) Science Edition (Thomson ISI) * Science Citation Index Expanded® (Thomson ISI) * Scopus (Elsevier).

Molecular Oncology highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational research. Topics include:• Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response.• Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems.•Biomarkers: diagnosis, prognosis, stratification and efficacy.• Cancer genetics, epigenetics, and genomic instability.• Minimal residual disease, pre-malignant lesions.• Cancer micro-environment.• Molecular pathology.• Tumour immunology.• Translational research.• Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment).• Chemotherapy, radiotherapy and surgery.• Clinical pharmacology.• Clinical trials, integration of basic science into cancer clinical trials.• Epidemiology and prevention.• Infrastructures (biobanks, databases, genomic resources).A main feature of the Journal is to provide an international forum for debating cancer issues, and for integrating the input of all the stakeholders.Coverage: Reviews, original articles, technical notes, editorials, news & views (commentary, science policy issues, ethical and legal issues, patient organisations, industry needs and alliances, regulatory issues, news items), letters to the editor, conference announcements, advertisements.Submitting Authors:Manuscripts can be submitted to Molecular Oncology at:http://ees.elsevier.com/molonc/

The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers carcinogenesis. To diagnose precancerous lesions and early-stage cancers quickly and accurately we need to detect the earliest molecular changes leading to each type of cancer. To determine a patient's prognosis we need to appreciate which molecular changes affect tumour growth rate and invasiveness. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a 'normal' cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied research. Nature Reviews Cancer will be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.Subjects covered * Genomic instability: chromosomal and microsatellite instabilities; defects in DNA repair pathways. * Growth factor signalling to cell cycle progression: proto-oncogenes and their dysregulation. * Growth inhibitory signals: dysregulation of quiescence and differentiation, tumour suppressors and their inactivation. * Cellular immortality and telomere maintenance. * Cell death: evading apoptosis, including avoidance of immune surveillance systems. * Angiogenesis: sustaining tumour growth by building a vascular system. * Metastasis: moving to and surviving in new environments. * Carcinogenesis and cancer prevention: epidemiology, genetic and environmental triggers, gene–environment interactions and strategies for reducing risk. * Cancer diagnosis and prognosis: molecular markers; diagnostic imaging; defining tumour margins; detecting minimal residual disease. * New approaches to cancer therapy: rational drug design, gene therapy, immunotherapy, combination therapies, combating drug resistance and targeting therapies to the individual. * Experimental systems and techniques: cell culture and animal models, genomic and proteomic approaches to studying cancer. * Cancer-associated disease: cancer pain, cachexia, symptoms associated with treatment (hair loss, anaemia, gastrointestinal disease), psychosocial aspects of cancer. * Ethical, legal and social issues surrounding cancer research: trial design, genetic screening, public and professional education, research policy and advocacy. * Conventional approaches to cancer diagnosis and treatment: how do they perform, what are their drawbacks and how might they be improved in the future?.

Neoplasia encourages the free exchange of all clones, cell lines, and biological reagents described in its pages to facilitate the progress of research in order to ultimately provide those fighting neoplastic diseases with new diagnostic, preventative and therapeutic options.

Published monthly from January 2010, Neuro-Oncology is the official journal of the Society for Neuro-Oncology. Also affiliated with the Japan Society for Neuro-Oncology and the European Association for Neuro-Oncology it is a truly global journal in the field.Dedicated to providing superior and rapid publication of information in all areas of neuro-oncology, the journal contains peer-reviewed articles and reviews, symposia on selected topics, published abstracts of annual meetings, and society news and announcements from around the world.